KEN LAUDAN joined Robinson-Humphrey in 2000. He has 10 years of
healthcare investment experience including Senior Research Analyst
positions at Montgomery Securities (now Banc of America Securities) and
Hambrecht & Quist (now Chase H&Q). Since 1992, Mr. Laudan has been
involved with nearly $2 billion worth of healthcare equity and M&A
assignments consisting of 15 different healthcare companies. He also is
a three-time Wall Street Journal All-Star Analyst. Mr. Laudan received a
BS Finance/Accounting from Kansas State University in 1982.
Specialty Pharmaceuticals: Ken Laudan - Robinson Humphrey Company Llc
April 09, 2001
